Litcius/Paper detail

Simultaneous Mapping of Vasculature, Hypoxia, and Proliferation Using Dynamic Susceptibility Contrast MRI, <sup>18</sup>F-FMISO PET, and <sup>18</sup>F-FLT PET in Relation to Contrast Enhancement in Newly Diagnosed Glioblastoma

Solène Collet, Jean‐Sébastien Guillamo, David Hassanein Berro, Ararat Chakhoyan, Jean‐Marc Constans, Emmanuèle Lechapt, Jean-Michel Derlon, Mathieu Hatt, Dimitris Visvikis, Stéphane Guillouet, Cécile Perrio, Myriam Bernaudin, Samuel Valable

2021Journal of Nuclear Medicine28 citationsDOIOpen Access PDF

Abstract

Conventional MRI plays a key role in the management of patients with high-grade glioma, but multiparametric MRI and PET tracers could provide further information to better characterize tumor metabolism and heterogeneity by identifying regions having a high risk of recurrence. In this study, we focused on proliferation, hypervascularization, and hypoxia, all factors considered indicative of poor prognosis. They were assessed by measuring uptake of 18 F-3'-deoxy-3'-18 F-fluorothymidine ( 18 F-FLT), relative cerebral blood volume (rCBV) maps, and uptake of 18 F-fluoromisonidazole ( 18 F-FMISO), respectively. For each modality, the volumes and high-uptake subvolumes (hot spots) were semiautomatically segmented and compared with the contrast enhancement (CE) volume on T1-weighted gadolinium-enhanced (T1w-Gd) images, commonly used in the management of patients with glioblastoma. Methods: Dynamic susceptibility contrastenhanced MRI (31 patients), 18 F-FLT PET (20 patients), or 18 F-FMISO PET (20 patients), for a total of 31 patients, was performed on preoperative glioblastoma patients. Volumes and hot spots were segmented on SUV maps for 18 F-FLT PET (using the fuzzy locally adaptive bayesian algorithm) and 18 F-FMISO PET (using a mean contralateral image 1 3.3 SDs) and on rCBV maps (using a mean contralateral image 1 1.96 SDs) for dynamic susceptibility contrast-enhanced MRI and overlaid on T1w-Gd images. For each modality, the percentages of the peripheral volumes and the peripheral hot spots outside the CE volume were calculated. Results: All tumors showed highly proliferated, hypervascularized, and hypoxic regions. The images also showed pronounced heterogeneity of both tracers regarding their uptake and rCBV maps, within each individual patient. Overlaid volumes on T1w-Gd images showed that some proliferative, hypervascularized, and hypoxic regions extended beyond the CE volume but with marked differences between patients. The ranges of peripheral volume outside the CE volume were 1.6%-155.5%, 1.5%-89.5%, and 3.1%-78.0% for 18 F-FLT, rCBV, and 18 F-FMISO, respectively. All patients had hyperproliferative hot spots outside the CE volume, whereas hypervascularized and hypoxic hot spots were detected mainly within the enhancing region. Conclusion: Spatial analysis of multiparametric maps with segmented volumes and hot spots provides valuable information to optimize the management and treatment of patients with glioblastoma.

Topics & Concepts

Nuclear medicineCerebral blood volumeGlioblastomaPet imagingMedicineGliomaContrast (vision)PeripheralMagnetic resonance imagingPositron emission tomographyRadiologyPhysicsInternal medicineOpticsCancer researchGlioma Diagnosis and TreatmentMedical Imaging Techniques and ApplicationsMRI in cancer diagnosis
Simultaneous Mapping of Vasculature, Hypoxia, and Proliferation Using Dynamic Susceptibility Contrast MRI, <sup>18</sup>F-FMISO PET, and <sup>18</sup>F-FLT PET in Relation to Contrast Enhancement in Newly Diagnosed Glioblastoma | Litcius